CordenPharma is a leading CDMO focused on fast-growing complex niche drug modalities with end to end capabilities from early stage development to commercial large-scale manufacturing.
As a leading contract development and manufacturing organization (CDMO), CordenPharma serves over 450 biotech and pharma customers globally. Based in Switzerland with manufacturing and R&D sites across Europe and the US, the company operates through five technology platforms: peptides, lipids & carbohydrates, highly potent, injectables and small molecules.
CordenPharma's Head Office is located in Basel, Switzerland.
Global Sales
CordenPharma’s serves a global customer base of more than 450 pharmaceutical & biotechnology companies through 12 facilities in Europe and United States.
